Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with BRAF V600E-mutant (BRAF(V600E)) metastatic non-small cell lung cancer (NSCLC) from the phase 2 PHAROS study.Gregory J. Riely,Egbert F. Smit,Myung-Ju Ahn,Enriqueta Felip,Suresh S. Ramalingam,Anne S. Tsao,Melissa Lynne Johnson,Francesco Gelsomino,Raymond M. Esper,Ernest Nadal,Michael Offin,Mariano Provencio-Pulla, Gregory Alan Otterson,Ibiayi Dagogo-Jack,Ann Alcasid,Tiziana Usari,Keith D. Wilner,Nuzhat Pathan,Bruce E. JohnsonJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览30暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
